Masimo Company Description
Masimo is counting on the pulse oximetry monitoring market not being saturated. The company's Signal Extraction Technology (SET) noninvasively monitors arterial blood-oxygen saturation levels and pulse rates in patients. Masimo's product range offers pulse oximeters in both hand-held and stand-alone (bedside) form. Product benefits include provision of real-time information and elimination of signal interference, such as patient movements. The company primarily markets its products through direct sales representatives and distributors. It also licenses SET-based products to approximately 50 medical equipment companies, including Cardinal Health, Medtronic, Welch Allyn, and Zoll Medical.
View the Comprehensive Company Description for Masimo
The Company Description provides a historical perspective of Masimo's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Masimo's evolution in the marketplace.
